Literature DB >> 20923662

Role of the conformational versatility of the neurotrophin N-terminal regions in their recognition by Trk receptors.

Francesca Stanzione1, Luciana Esposito, Antonella Paladino, Carlo Pedone, Giancarlo Morelli, Luigi Vitagliano.   

Abstract

Neurotrophins (NTs) represent a family of proteins that play an important role in the survival, development, and function of neurons. Extensive efforts are currently being made to develop small molecules endowed with agonist or antagonist NT activity. The structurally versatile N-termini of these proteins are considered regions of interest for the design of new molecules. By combining experimental and computational approaches, we analyzed the intrinsic conformational preferences of the N-termini of two of the most important NTs: NGF (NGF-Nter) and NT4 (NT4-Nter). Circular dichroism spectra clearly indicate that both peptides show a preference for random coil states. Because this finding does not preclude the possibility that structured forms may occur in solution as minor conformational states, we performed molecular-dynamics simulations to gain insights into the structural features of populated species. In line with the circular dichroism analysis, the simulations show a preference for unstructured states for both peptides. However, the simulations also show that for NT4-Nter, and to a lesser extent for NGF-Nter, helical conformations, which are required for binding to the Trk receptor, are present in the repertoire of structures that are intrinsically accessible to these peptides. Accordingly, molecular recognition of NTs by the Trk receptor is accomplished by the general mechanism known as population shift. These findings provide a structural rationale for the observed activity of synthetic peptides based on these NT regions. They also suggest strategies for the development of biologically active peptide-based compounds.
Copyright © 2010 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20923662      PMCID: PMC3042551          DOI: 10.1016/j.bpj.2010.07.054

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  38 in total

Review 1.  Protein-protein interactions in receptor activation and intracellular signalling.

Authors:  T L Blundell; D F Burke; D Chirgadze; V Dhanaraj; M Hyvönen; C A Innis; E Parisini; L Pellegrini; M Sayed; B L Sibanda
Journal:  Biol Chem       Date:  2000 Sep-Oct       Impact factor: 3.915

Review 2.  Small molecule peptidomimetic ligands of neurotrophin receptors, identifying binding sites, activation sites and regulatory sites.

Authors:  H Uri Saragovi; Maria Clara Zaccaro
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

Review 3.  Nerve growth factor: structure and function.

Authors:  C Wiesmann; A M de Vos
Journal:  Cell Mol Life Sci       Date:  2001-05       Impact factor: 9.261

Review 4.  A neurotrophic rationale for the therapy of neurodegenerative disorders.

Authors:  H Uri Saragovi; Edith Hamel; Adriana Di Polo
Journal:  Curr Alzheimer Res       Date:  2009-10       Impact factor: 3.498

5.  Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex with neurotrophin-4/5.

Authors:  M J Banfield; R L Naylor; A G Robertson; S J Allen; D Dawbarn; R L Brady
Journal:  Structure       Date:  2001-12       Impact factor: 5.006

6.  Nerve growth factor (NGF) loop 4 dimeric mimetics activate ERK and AKT and promote NGF-like neurotrophic effects.

Authors:  Y Xie; M A Tisi; T T Yeo; F M Longo
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

7.  Molecular dynamics simulations of the NGF-TrkA domain 5 complex and comparison with biological data.

Authors:  Giovanni Settanni; Antonino Cattaneo; Paolo Carloni
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

8.  Design of potent peptide mimetics of brain-derived neurotrophic factor.

Authors:  Paul D O'Leary; Richard A Hughes
Journal:  J Biol Chem       Date:  2003-05-02       Impact factor: 5.157

9.  Alzheimer's therapeutics: neurotrophin small molecule mimetics.

Authors:  Stephen M Massa; Youmei Xie; Frank M Longo
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

Review 10.  Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?

Authors:  Stuart C Apfel
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

View more
  2 in total

1.  Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor.

Authors:  Francesca Paoletti; Cesira de Chiara; Geoff Kelly; Sonia Covaceuszach; Francesca Malerba; Robert Yan; Doriano Lamba; Antonino Cattaneo; Annalisa Pastore
Journal:  Front Mol Biosci       Date:  2016-12-26

2.  Trk Receptors and Neurotrophin Cross-Interactions: New Perspectives Toward Manipulating Therapeutic Side-Effects.

Authors:  Yazan Haddad; Vojtěch Adam; Zbyněk Heger
Journal:  Front Mol Neurosci       Date:  2017-05-03       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.